Introduction
Cardiopulmonary resuscitation (CPR) is a widely known procedure used to save lives when patients undergo cardiac arrest. However, despite being extensively taught and used, CPR remains ineffective. A meta-analysis has shown that 23.8% of out-of-hospital CPR patients survive to admission, and a mere 7.6% of these patients ultimately survive to be discharged from the hospital [1] . Even when CPR takes place in hospital setting, the overall survival rates are not encouraging. It is reported that <50% of patients survive CPR [2] [3] [4] , while < 20% of patients survive to discharge [2, 4] . These results suggest that when traditional CPR is not effective, alternate means of resuscitation are necessary.
As ECMO rises in popularity and use, there has been increasing interest in its viability and success when used during CPR (E-CPR). E-CPR provides a method to stabilize hemodynamics and provide end-organ perfusion when traditional CPR is inadequate and the cause of cardiac arrest is reversible. While many studies have assessed the efficacy of E-CPR in pediatric populations [5] [6] [7] , fewer have investigated it in an adult population. The studies of adult populations have assessed the success of E-CPR in adult populations by mortality, and many have not taken end-organ function into account.
In a study that assessed the survival benefits of E-CPR compared to conventional CPR after a witnessed arrest, E-CPR provided a significantly higher return of spontaneous circulation, and a ~ 20% increase in survival rate at discharge [8] . Further studies on E-CPR have shown an increased rate of survival at 1-year [8] , and 2-years [9] after discharge when compared to conventional CPR. Many of these studies on adult E-CPR have taken place under optimal conditions in institutions that have designated teams of E-CPR specialists, ready to cannulate patients as a part of the Code Team [8] [9] [10] .
Through this investigation, there will be greater understanding of the benefits to be gained from E-CPR, such as successful hospital discharge with limited neurological damage, or organ procurement in non-survivors. If shown to be effective, this study will assert that E-CPR should be considered during in-hospital cardiac arrests.
Methods
From June 2010 through July 2014 a total of 107 adult ECMO procedures were done at our institution. Of those 107 procedures, 23 patients had E-CPR after failing to respond to traditional CPR. All E-CPR candidates were in-patients with a witnessed arrest, and the ECMO team was notified less than 20 minutes following the initial arrest. Our institution's E-CPR protocol was applied to all patients as follows; the attending physician in charge of a Code Blue determined whether ECMO was feasible within 20 minutes of unsuccessful resuscitation based on the exclusion criteria: patient's age > 70 years old; the presence of a patient's 'Do Not
Resuscitate' orders; whether the patient has an uncorrectable baseline disease such as terminal cancer, advanced coronary artery disease, or a previous neurological deficit; if the patient has uncontrolled sepsis or bleeding. The code team notified the attending physician on call in the surgical cardiovascular ICU, who immediately evaluated the patient's risks and benefits. If all parties were in agreement that ECMO was necessary, the patient was cannulated at the bedside.
Perfusionists were called in to set up the ECMO circuit. CPR was continued until ECMO was initiated; all E-CPR patients were started on veno-arterial ECMO. The cannulation procedure was followed as outlined by Lamb and colleagues in order to minimize the risk of excessive bleeding and limb ischemia [11] . Patients who underwent CPR, but no longer required CPR during ECMO cannulation were excluded from this study. [14] , and sequential organ failure assessment (SOFA) [15] scores were calculated based on the pre-ECMO, peri-ECMO and post-ECMO data.
Statistical analyses were performed using Chi-square or Fisher's exact tests for categorical variables and Student's t-tests for continuous variables, as appropriate, to identify the risk factors for ECMO death. Similar analyses were performed to identify the risk factors for hospital death among the ECMO survivors. Our sample size was too small for a multivariate analysis. The results were expressed as number with percentage, or mean ± standard deviation.
P-values < .05 were considered to be significant.
Results

Patients:
The 23 patients who received E-CPR at our institution consisted of 15 males and 8
females with a mean age of 46 ± 12 years. The primary diagnoses leading to E-CPR in the patients were acute myocardial infraction (AMI) (n=9), non-ischemic malignant ventricular tachy-arrhythmia (n=5), myocarditis (n=2), acute pulmonary embolus (n=2), hypothermia (n=2), acute rejection (n=1), drug induced cardiac arrest (n=1), and post-cardiotomy failure (n=1). The initial cardiac rhythms in E-CPR patients were ventricular tachycardia or fibrillation (n=8) or pulseless electrical activity (n=15). All patients with a ventricular tachyarrhythmia received electrical defibrillation or cardioversion as appropriate; however, all 8 patients deteriorated into pulseless electrical activity or cardiac arrest prior to the establishment of ECMO. E-CPR was performed in the intensive care unit (ICU) (n=9), catheterization lab (n=7), emergency department (n=5), and operating room (n=2). Of the patients who had an AMI, 2 patients had a percutaneous coronary intervention (PCI) prior to ECMO. The average time of CPR prior to ECMO was 54 ± 30 min. With the exception of 2 patients, all underwent femoral cannulation as described previously. The remaining patients had an open sternum and were cannulated centrally between the aorta and the right atrium.
ECMO survival: Following E-CPR, the average time on ECMO was 6.2 ± 5.5 days. 14 patients (61%) survived ECMO and 9 patients (39%) died while on ECMO (Figure 1 ). The causes of death in patients who died on ECMO were anoxic brain injury (n=4), stroke (n=4), and bowel necrosis (n=1). Among the patients who suffered an anoxic brain injury, 2 donated multiple organs for transplant. Among the 14 ECMO survivors, 13 had unchanged or improved status in at least one organ (liver function improved or unchanged in 13, kidney function improved or unchanged in 13, and lactate improved in 12, unchanged in 1 as shown in Table 1 ). Acute renal failure occurred during ECMO in 5 patients. All 5 of these patients were managed by CVVHD during ECMO treatment. Among the patients who survived ECMO, two were post-cardiotomy failure status post coronary artery bypass graft. Of the variables tested pertaining to patient demographics, clinical risk factors, and pre-ECMO laboratory data, only pre-ECMO creatinine levels (p=0.022), and pre-ECMO pH (p=0.039) correlated with ECMO survival (Table 2) . No verified ICU or disease-specific risk scores pre-ECMO had a correlation with E-CPR survival (Table 2 ). On ECMO, cardiac (myocardial standstill, [p=0.034]), and any neurological complications (stroke and anoxic brain injury) (p=0.001) were factors correlated with death during ECMO (Table 3) . Of the risk scores calculated with data from 24 hours after ECMO initiation, the MELD, SOFA, and APACHE II scores were correlated with ECMO survival after E-CPR (Table 4) . Isolated data from 24 hours after ECMO initiation associated with ECMO survival included: lactate levels (survivors: 3.7 ± 2.5; non survivors: 8.8 ± 5.3; p=0.015), bicarbonate levels (survivors: 27.1 ± 2.7; non survivors: 22.6 ± 1.3; p= 0.0001), and creatinine levels (survivors: 1.3 ± 0.5; non survivors: 1.9 ± 0.5; p= 0.007).
Hospital Survival: Seven of the 14 patients (50%) who survived ECMO were successfully discharged from the hospital, yielding a hospital survival rate of 30% (7/23) (Figure 1 ). The causes of death in the seven patients who died following successful ECMO decannulation were anoxic brain injury post cardiac arrest despite cooling and ECMO (n=2), stroke (n=1), brain death from unknown reason (n=2), sepsis (n=1), and AMI from the non-revascularized coronary artery (n=1). All causes of death appeared to be related to the initial insult leading to cardiac
arrest. Of the variables tested pertaining to patient demographics, clinical risk factors, pre-ECMO laboratory data and/or disease-specific risk scores, only pre-ECMO bilirubin levels were correlated with hospital survival (p=0.040) ( Table 5) . No pre-ECMO ICU or disease-specific risk scores were found to correlate with hospital survival after E-CPR. Risk scores taken 24
hours after the initiation of ECMO were not found to have a significant correlation with hospital survival after E-CPR. The only isolated data from 24 hours after ECMO initiation associated with hospital survival was 24-hour PaO2 (survivors: 197 ± 115; non survivors: 248 ± 110; p=0.037) which had an association with hospital survival. 1 patient who developed acute renal failure survived ECMO but died before discharge. The overall length of the hospital stay after E-CPR was 43 ± 28 days. All patients who were discharged from the hospital did not demonstrate any gross neurological deficits during a follow up visit 4-6 weeks following discharge from a rehabilitation facility. No patients discharged from the hospital were bed-ridden. There were no limitations of daily activity at 6-8 week follow-ups from the date of discharge.
Discussion
CPR is a technique used around the world to allow patients a second chance at life.
When traditional CPR fails in a hospital setting, there are alternative procedures for resuscitation.
With the popularity of ECMO growing, and the number of ECMO trained individuals increasing, E-CPR can provide a method by which a patient can be resuscitated when traditional CPR is ineffective.
The present study assesses the survival rate, neurological recovery and end organ function of E-CPR patients in our institution, while attempting to identify risk factors for patients undergoing E-CPR. When compared to previously published CPR survival rates (<20%), our E-CPR survival rate demonstrated reasonable recovery for arrested patients [2, 4] .
Technical issues of cannulation during E-CPR remain an issue that has been discussed in the literature. A previous study showed an ischemia complication rate of 30% [27] . However, using our E-CPR technique, including standard peripheral cannulation and the use of distal profusion catheters in all patients, the risk of lower leg ischemia complications has been lowered dramatically.
Our study supports a number of findings from an E-CPR study done in pediatric patients, which demonstrated that patient demographic factors such as age, weight and sex do not effect survival [6] , and another paper indicating a correlation with duration of ECMO [16] . Our study also partially agrees with major conclusions from previous studies of adult E-CPR patients, which indicate that a state of acidosis is correlated with poor E-CPR outcomes [20] . However, our results contradicted the findings of a number of other studies, including those which claimed that low inotrope levels, low pre-ECMO lactate levels, shorter CPR duration, and low pre-ECMO SOFA scores were associated with favorable outcomes in E-CPR patients [17] [18] [19] . We found no association between any pre-ECMO risk scores (MELD, SAPS II, SOFA, APACHE II) and ECMO survival. Different from previous reports, the current study investigated end-organ function to determine if ECMO allowed a patient's vital organs to remain in functional condition. Many prior studies have not completed a similar examination.
Interestingly, some of the strongest correlations found in the present study relate to values taken 24 hours after the initiation of ECMO. The MELD, SOFA and APACHE II scores taken at this time point significantly predicted ECMO survival, with a higher score yielding a worse prognosis. Knowing this, along with completing a neurological evaluation, provides clinicians with a benchmark to form a prognosis of whether the patient will survive ECMO following E-CPR. Rather than having to wait a number of days, by calculating MELD, SOFA and APACHE II scores 24 hours after E-CPR, physicians and families can gain better insight into the ultimate chances the patient has at survival.
Neurological complications remain a major cause of patient death. Although one patient who developed a stroke during ECMO survived ECMO, the majority of patients who suffered from anoxic brain injuries or strokes during ECMO developed clinical brain death. Despite the nature of ECMO, and the hypothermia protocols initiated, we found that 8 patients (35%) had clinical brain death while on ECMO, and an additional four patients (17%) had major neurological events after ECMO removal, thus limiting their survival. The timing and causative factors for the neurological events were unclear, and neurological protection remains important in improving the survival after E-CPR. That being said, the neurological recovery among hospital survivors was encouraging. All of the hospital survivors in our study were successfully discharged without any gross neurological deficits. ECMO treatment has been associated with the risk of neurological complications, with E-CPR raising that risk even further [21] [22] . Prior studies have compared the efficacy of E-CPR to conventional CPR in preventing long-term neurological damage, and have shown that E-CPR is significantly better at neurological protection than conventional CPR [9] . Recently, a single center observational study assessing the use of aggressive E-CPR combined with hypothermia for cardiac arrest patients demonstrated similar results of full neurological recovery for the E-CPR survivors [28] .
Organ preservation is another benefit of ECMO treatment. In all but one of the E-CPR survivors, organ function was either improved or unchanged (Table 1) . This is a phenomenon that has previously been associated with beneficial outcomes from ECMO treatment [23] .
Furthermore, in two patients who did not survive ECMO and died of anoxic brain injury, solid organs were harvested for transplantation. The procurement and sustained function of organs from ECMO non-survivors is a distinct benefit to be gained from ECMO, as reported previously by our group and others [24] [25] [26] . Results from our current study demonstrated the efficacy of E-CPR in also allowing organs to be harvested for transplantation in patients who have suffered an anoxic brain injury. Organ procurement is clearly a topic that has many potential ethical implications, though, and this study does not thoroughly investigate the boundaries that physicians should adhere to when attempting to procure an organ for transplant.
This study was limited due to its retrospective nature, and small sample size. Many patients who received CPR at our institution during the study period were not candidates for ECMO due to their age, various comorbidities, and access to ECMO circuits. In the present setting at our institution, the ECMO team is not a regular part of the Code Team. This leads to limitations as to when E-CPR can be performed due to variable availability of attending physicians, perfusionists and ECMO circuits. This is a setting that differs from that described in a number of previous reports on E-CPR [8] [9] [10] . Ideally, our E-CPR sample could have been compared to an internal control group, but our hospital CPR records are incompletely documented, and the CPR patient population differed from ours. While there were nearly 450
Code Blues at our institution during this time period, only 23 patients were given E-CPR. This may have led to bias as to who was treated with E-CPR rather than conventional CPR.
Conclusion
E-CPR provides a viable alternative to traditional CPR for patients refractory to conventional resuscitation measures. E-CPR should be strongly considered when the materials and personnel are available, and patients are unresponsive to conventional CPR. The proper use of E-CPR may greatly improve hospital outcomes for patients who suffer an in-hospital cardiac arrest. Lactate (mmol/L) 7.0 ± 5.4 2.1 ± 1.5
Murray score 2 ± 1 1 ± 1 
